| Further characterization of Clostridium perfringens small acid soluble protein-4 (Ssp4) properties and expression. Li J., Paredes-Sabja D., Sarker M.R., McClane B.A.
PLoS ONE 4:e6249-e6249(2009) · UniProtKB (1) |
| Sequencing and diversity analyses reveal extensive similarities between some epsilon-toxin-encoding plasmids and the pCPF5603 Clostridium perfringens enterotoxin plasmid. Miyamoto K., Li J., Sayeed S., Akimoto S., McClane B.A.
J. Bacteriol. 190:7178-7188(2008) · UniProtKB (69) |
| Structure of the claudin-binding domain of Clostridium perfringens enterotoxin. Van Itallie C.M., Betts L., Smedley J.G., McClane B.A., Anderson J.M.
J. Biol. Chem. 283:268-274(2008) · Mapped (1) |
| Comparison of virulence plasmids among Clostridium perfringens type E isolates. Li J., Miyamoto K., McClane B.A.
Infect. Immun. 75:1811-1819(2007) · UniProtKB (2) |
| Both epsilon-toxin and beta-toxin are important for the lethal properties of Clostridium perfringens type B isolates in the mouse intravenous injection model. Fernandez-Miyakawa M.E., Fisher D.J., Poon R., Sayeed S., Adams V., Rood J.I., McClane B.A., Uzal F.A.
Infect. Immun. 75:1443-1452(2007) · UniProtKB (1) |
| Dissecting the contributions of Clostridium perfringens type C toxins to lethality in the mouse intravenous injection model. Fisher D.J., Fernandez-Miyakawa M.E., Sayeed S., Poon R., Adams V., Rood J.I., Uzal F.A., McClane B.A.
Infect. Immun. 74:5200-5210(2006) · UniProtKB (2) |
| Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens. Myers G.S.A., Rasko D.A., Cheung J.K., Ravel J., Seshadri R., DeBoy R.T., Ren Q., Varga J., Awad M.M., Brinkac L.M. et al.
Genome Res. 16:1031-1040(2006) · UniProtKB (5,484) |
| Complete sequencing and diversity analysis of the enterotoxin-encoding plasmids in Clostridium perfringens type A non-food-borne human gastrointestinal disease isolates. Miyamoto K., Fisher D.J., Li J., Sayeed S., Akimoto S., McClane B.A.
J. Bacteriol. 188:1585-1598(2006) · UniProtKB (159) |
| Association of beta2 toxin production with Clostridium perfringens type A human gastrointestinal disease isolates carrying a plasmid enterotoxin gene. Fisher D.J., Miyamoto K., Harrison B., Akimoto S., Sarker M.R., McClane B.A.
Mol. Microbiol. 56:747-762(2005) · UniProtKB (24) |
| Organization of the plasmid cpe Locus in Clostridium perfringens type A isolates. Miyamoto K., Chakrabarti G., Morino Y., McClane B.A.
Infect. Immun. 70:4261-4272(2002) · UniProtKB (10) |
| Clostridium perfringens type E animal enteritis isolates with highly conserved, silent enterotoxin gene sequences. Billington S.J., Wieckowski E.U., Sarker M.R., Bueschel D., Songer J.G., McClane B.A.
Infect. Immun. 66:4531-4536(1998) · UniProtKB (1) |
| Cloning, nucleotide sequencing, and expression of the Clostridium perfringens enterotoxin gene in Escherichia coli. Czeczulin J.R., Hanna P.C., McClane B.A.
Infect. Immun. 61:3429-3439(1993) · UniProtKB (1) |
| Molecular cloning of the 3' half of the Clostridium perfringens enterotoxin gene and demonstration that this region encodes receptor-binding activity. Hanna P.C., Wnek A.P., McClane B.A.
J. Bacteriol. 171:6815-6820(1989) · UniProtKB (1) |
in Literature Citations
